The potential market for the drugs is massive — more than 40 percent of adults in the U.S. are obese — and has seen explosive ...

CVS’s stock soared toward a three-month high after its quarterly profit beat expectations by the widest margin in more than four years.

Nineteen companies, led by Pfizer, Johnson & Johnson, and UnitedHealth, accounted for 80% of payouts. Researchers suggest ...

From soaring drug expenses in the Great Plains to rising supply costs in the West, regional disparities highlight the unique pressures facing hospital leaders. As labor shortages persist, supply ...

Recently, a letter to the editor I wrote was published in the Arkansas Democrat-Gazette on the subject of skyrocketing health-care costs, inclusive of rising pharmaceutical drug prices. I referenced ...

Payouts to shareholders of large publicly traded health companies more than tripled over the past two decades, new research ...

Tariffs and price inflation for specialty medications will increase costs, according to research from Vizient.

The root of the U.S.’s high prescription drug prices lies in its unique system, which allows pharmaceutical manufacturers to ...

The FTC called out the nation’s leading pharmacy benefit managers for inflating pharmacy costs, affecting both employers and ...

The cost of cancer may be higher than previously estimated, according to a recent report from the American Cancer Society.